Insider tradingForm 4
RHYTHM PHARMACEUTICALS, INC. (RYTM) Insider Trading
6 open-market trades reported since Aug 14, 2026: 0 purchases worth $0 and 6 sales worth $28.8M.
By insider
| Insider | Role | Buys | Bought | Sells | Sold |
|---|---|---|---|---|---|
| David P. Meeker | CEO | 0 | $0 | 1 | $5.13M |
| Hunter C. Smith | CFO | 0 | $0 | 1 | $6.62M |
| Alastair Garfield | Chief Scientific Officer | 0 | $0 | 1 | $913K |
| Joseph Shulman | Chief Technical Officer | 0 | $0 | 1 | $608K |
| Jennifer Kayden Lee | EVP | 0 | $0 | 1 | $8.90M |
| Yann Mazabraud | EVP | 0 | $0 | 1 | $6.62M |
All trades
| Filed | Insider | Type | Value | 3 mo. after |
|---|---|---|---|---|
| Sep 14 | David P. MeekerCEO | ▼ SELL10b5-1 | $5.13M | |
| Sep 1 | Hunter C. SmithCFO | ▼ SELL10b5-1 | $6.62M | |
| Aug 17 | Alastair GarfieldChief Scientific Officer | ▼ SELL10b5-1 | $913K | |
| Aug 17 | Joseph ShulmanChief Technical Officer | ▼ SELL10b5-1 | $608K | |
| Aug 14 | Jennifer Kayden LeeEVP | ▼ SELL10b5-1 | $8.90M | |
| Aug 14 | Yann MazabraudEVP | ▼ SELL10b5-1 | $6.62M |
Source: SEC Form 4 filings, retrieved Oct 28, 2026. How we read filings